Dogwood Therapeutics, Inc.
No enriched coverage for $DWTX in the last 7 days.
No SEC Form 4 filings for $DWTX in the last 30 days.
ATLANTA, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Dogwood Therapeutics, Inc. DWTX ( the "Company" ) , a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in the H.C. Wainwright 27th Annual Global ...
ATLANTA, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Dogwood Therapeutics, Inc. ( Nasdaq: DWTX ) ( the "Company" ) , a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announces it will participate in the H.C.
ATLANTA, June 03, 2025 ( GLOBE NEWSWIRE ) -- Dogwood Therapeutics, Inc. ( Nasdaq: DWTX ) ( "Dogwood" or the "Company" ) , a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announced that CEO, Greg Duncan, will present a ...
